Post a Comment Print Share on Facebook

reads.

The majority is in favour of the agreement with the EU

According to the first representative survey on the institutional agreements, the research Institute gfs.bern to support 60 percent of the Swiss are currently the present draft of the framework agreement. 35 per cent of the Swiss Voting against the agreement critical. The poll was commissioned by the pharmaceutical Association interpharma in order.

in General, the bilateral agreements are evaluated more positive than in previous years. The population sees a clear connection between stable relations with the EU and the prosperity of Switzerland. The support for the institutional agreement that runs through almost all the political parties, with the exception of the SVP, and is found in the two largest regions (58 per cent for the German speaking part of Switzerland, and 69 per cent for French-speaking Switzerland) spoke again.

The reasons why you are Voting for or against the agreement in the votes, based mainly on economic Considerations. So, over two thirds (69 per cent) of all survey participants that the framework agreement of the Swiss economy provides the necessary legal and planning security. While 64 percent of all respondents in the Erosion according to the survey of the existing market access agreements be aware of.

pharmaceutical industry illustrate the framework agreement

"The results of the survey, the Swiss population of the importance of the bilateral agreements is aware of," says René Buholzer, managing Director of inter-Pharma, in a press release. The opinion of the institutional agreement have begun, and there is continuous persuasion need work, the importance of stable relationships to highlight our most important economic partner.

For the pharmaceutical industry, in particular the agreement on technical barriers to trade and the free movement of persons are crucial. In order to obtain the bilateral way, the Expansion of market access further and to prevent the Erosion of existing market access agreements, and considers inter-Pharma-institutional agreement between Switzerland and the EU as necessary. (hvw/sda)

Created: 31.03.2019, 10:48 PM

Avatar
Your Name
Post a Comment
Characters Left:
Your comment has been forwarded to the administrator for approval.×
Warning! Will constitute a criminal offense, illegal, threatening, offensive, insulting and swearing, derogatory, defamatory, vulgar, pornographic, indecent, personality rights, damaging or similar nature in the nature of all kinds of financial content, legal, criminal and administrative responsibility for the content of the sender member / members are belong.